BridgeBio Pharma
BBIO
BBIO
247 hedge funds and large institutions have $6.76B invested in BridgeBio Pharma in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 89 increasing their positions, 77 reducing their positions, and 26 closing their positions.
Holders
247
Holders Change
+26
Holders Change %
+11.76%
% of All Funds
3.62%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.22%
New
53
Increased
89
Reduced
77
Closed
26
Calls
$110M
Puts
$90.1M
Net Calls
+$20.2M
Net Calls Change
-$12.9M
Top Buyers
| 1 |
1
Lord, Abbett & Co
Jersey City,
New Jersey
|
$125M |
| 2 |
2
Morgan Stanley
New York
|
$134M |
| 3 |
3
Goldman Sachs
New York
|
$132M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$517M |
| 5 |
5
BlackRock
New York
|
$410M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
276
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
277
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
|
LP
278
LMR Partners
London,
United Kingdom
| – | – | – | – |
|
|
EP
279
Eversept Partners
New York
| – | – | – | – |
|
|
FIA
280
FNY Investment Advisers
New York
| – | – | – | – |
|
|
CFGS
281
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
282
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
WAM
283
Wolverine Asset Management
Chicago,
Illinois
| – | – | – | – |
|
284
Walleye Trading
New York
| – | – | – | – |
|